Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

Article  PubMed  Google Scholar 

Chandra S, Goswami A, Mandal P. Molecular heterogeneity of cervical cancer among different ethnic/racial populations. J Racial Ethn Health Disparities. 2022;9(6):2441–50.

Article  PubMed  Google Scholar 

Park JH, Pyun WY, Park HW. Cancer metabolism: phenotype, signaling and therapeutic targets. Cells. 2020;9(10):2308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T, Copeland C, Le A. Glutamine metabolism in cancer. Adv Exp Med Biol. 2021;1311:17–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin J, Byun JK, Choi YK, Park KG. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55(4):706–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cluntun AA, Lukey MJ, Cerione RA, Locasale JW. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer. 2017;3(3):169–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonçalves AC, Richiardone E, Jorge J, Polónia B, Xavier CPR, Salaroglio IC, Riganti C, Vasconcelos MH, Corbet C, Sarmento-Ribeiro AB. Impact of cancer metabolism on therapy resistance - clinical implications. Drug Resist Updat. 2021;59:100797.

Article  PubMed  Google Scholar 

Li C, Wu H, Guo L, Liu D, Yang S, Li S, Hua K. Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer. Commun Biol. 2022;5(1):1208.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Li J, Ma J, Hasim A. Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1-mediated fatty acid synthesis. Mol Oncol. 2024. Epub ahead of print.

Das S, Babu A, Medha T, Ramanathan G, Mukherjee AG, Wanjari UR, Murali R, Kannampuzha S, Gopalakrishnan AV, Renu K, et al. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients. Med Oncol. 2023;40(5):149.

Article  PubMed  PubMed Central  Google Scholar 

Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81–94.

Article  CAS  PubMed  Google Scholar 

Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28.

Article  PubMed  PubMed Central  Google Scholar 

Li S, Zeng H, Fan J, Wang F, Xu C, Li Y, Tu J, Nephew KP, Long X. Glutamine metabolism in breast cancer and possible therapeutic targets. Biochem Pharmacol. 2023;210:115464.

Article  CAS  PubMed  Google Scholar 

Pecchillo Cimmino T, Pagano E, Stornaiuolo M, Esposito G, Ammendola R, Cattaneo F. Formyl-peptide receptor 2 signaling redirects glucose and glutamine into anabolic pathways in metabolic reprogramming of lung cancer cells. Antioxidants (Basel). 2022;11(9):1692.

Article  CAS  PubMed  Google Scholar 

Chakraborty S, Balan M, Sabarwal A, Choueiri TK, Pal S. Metabolic reprogramming in renal cancer: events of a metabolic disease. Biochim Biophys Acta Rev Cancer. 2021;1876(1):188559.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Encarnación-Rosado J, Sohn ASW, Biancur DE, Lin EY, Osorio-Vasquez V, Rodrick T, González-Baerga D, Zhao E, Yokoyama Y, Simeone DM, et al. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism. Nat Cancer. 2024;5(1):85–99.

Article  PubMed  Google Scholar 

Wettersten HI, Aboud OA, Lara PN Jr, Weiss RH. Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol. 2017;13(7):410–9.

Article  CAS  PubMed  Google Scholar 

Xiao-Yan W, Xiao-Xia Y, Peng-Fei S, Zong-Xue Z, Xiu-Li G. Metabolic reprogramming of glutamine involved in tumorigenesis, multidrug resistance and tumor immunity. Eur J Pharmacol. 2023;940:175323.

Article  PubMed  Google Scholar 

van Geldermalsen M, Wang Q, Nagarajah R, Marshall AD, Thoeng A, Gao D, Ritchie W, Feng Y, Bailey CG, Deng N, et al. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene. 2016;35(24):3201–8.

Article  PubMed  Google Scholar 

He MJ, Pu W, Wang X, Zhang W, Tang D, Dai Y. Comparing DESI-MSI and MALDI-MSI mediated spatial metabolomics and their applications in cancer studies. Front Oncol. 2022;12:891018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu F, Fan J, He Y, Xiong A, Yu J, Li Y, Zhang Y, Zhao W, Zhou F, Li W, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12(1):2540.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, De Marzo AM, Nelson PS, Yegnasubramanian S. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol. 2021;18(2):79–92.

Article  PubMed  Google Scholar 

Huang X, Gan G, Wang X, Xu T, Xie W. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Autophagy. 2019;15(7):1258–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma G, Liang Y, Chen Y, Wang L, Li D, Liang Z, Wang X, Tian D, Yang X, Niu H. Glutamine deprivation induces PD-L1 Expression via activation of EGFR/ERK/c-Jun signaling in renal cancer. Mol Cancer Res. 2020;18(2):324–39.

Article  CAS  PubMed  Google Scholar 

Reynolds MR, Lane AN, Robertson B, Kemp S, Liu Y, Hill BG, Dean DC, Clem BF. Control of glutamine metabolism by the tumor suppressor Rb. Oncogene. 2014;33(5):556–66.

Article  CAS  PubMed  Google Scholar 

Eelen G, Dubois C, Cantelmo AR, Goveia J, Brüning U, DeRan M, Jarugumilli G, van Rijssel J, Saladino G, Comitani F, et al. Role of glutamine synthetase in angiogenesis beyond glutamine synthesis. Nature. 2018;561(7721):63–9.

Article  CAS  PubMed  Google Scholar 

Noda-Garcia L, Liebermeister W, Tawfik DS. Metabolite-enzyme coevolution: from single enzymes to metabolic pathways and networks. Annu Rev Biochem. 2018;87:187–216.

Article  CAS  PubMed  Google Scholar 

Scalise M, Console L, Cosco J, Pochini L, Galluccio M, Indiveri C. ASCT1 and ASCT2: brother and sister? SLAS Discov. 2021;26(9):1148–63.

Article  CAS  PubMed  Google Scholar 

Zhang D, Wang M, Huang X, Wang L, Liu Y, Zhou S, Tang Y, Wang Q, Li Z, Wang G. GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights. Front Oncol. 2023;13:1220038.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Zhao T, Li Z, Wang L, Yuan S, Sun L. The role of ASCT2 in cancer: a review. Eur J Pharmacol. 2018;837:81–7.